beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
about
Telomerase deficiency impairs glucose metabolism and insulin secretionMetabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)Synaptotagmin-7 phosphorylation mediates GLP-1-dependent potentiation of insulin secretion from β-cellsInterventions to preserve beta-cell function in the management and prevention of type 2 diabetesThe central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetesPICK1 and ICA69 control insulin granule trafficking and their deficiencies lead to impaired glucose toleranceNov/Ccn3, a novel transcriptional target of FoxO1, impairs pancreatic β-cell functionDistinct actions of Rab3 and Rab27 GTPases on late stages of exocytosis of insulin.Newly diagnosed diabetes mellitus as a risk factor for serious liver diseaseMisfolded proinsulin affects bystander proinsulin in neonatal diabetesThe once-daily human glucagon-like peptide-1 analog, liraglutide, improves β-cell function in Japanese patients with type 2 diabetes.MicroRNA-7a regulates pancreatic β cell function.Insulin regulates carboxypeptidase E by modulating translation initiation scaffolding protein eIF4G1 in pancreatic β cells.Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional studyBLX-1002 restores glucose sensitivity and enhances insulin secretion stimulated by GLP-1 and sulfonylurea in type 2 diabetic pancreatic islets.Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients.The insulin gene in diabetes.Genetically defined pancreatic beta cell failure.Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes?PKA Enhances the Acute Insulin Response Leading to the Restoration of Glucose Control.Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells.Targeting beta-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review.The pancreatic beta cell surface proteome.Prevalence and Predictors of Metabolic Syndrome in Young Asymptomatic Gujarati Populationβ-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretionIs the indicator magnifying window for insulin pens helpful for elderly diabetic patients?Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.Initiation and execution of lipotoxic ER stress in pancreatic beta-cells.Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial.PI3 kinases p110α and PI3K-C2β negatively regulate cAMP via PDE3/8 to control insulin secretion in mouse and human islets.First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesisIndices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose.Endocrine secretory reserve and proinsulin processing in recipients of islet of langerhans versus whole pancreas transplants.Association of sleep apnea and type II diabetes: a population-based studyProteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion.Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein.Potent hyperglycemic and hyperinsulinemic effects of thyrotropin-releasing hormone microinjected into the rostroventrolateral medulla and abnormal responses in type 2 diabetic rats.Biophysical alteration of the secretory track in β-cells due to molecular overcrowding: the relevance for diabetes.ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1.
P2860
Q24633376-005D2FF2-BBE2-4991-8C6B-0F592A0A46EAQ24793496-CE950A63-9BE0-4047-A009-EA19BA9D952DQ26269824-BEBF112A-8D81-464A-8C07-9D8B3C7D3702Q26830871-2FBDC800-58F0-483A-93D8-D5BAFFD4B630Q26860579-0E9A3E76-0DB8-4A67-AB3B-317910FFF621Q27318067-799A7FC4-F895-4E7A-A675-A90B38D5DC9AQ28507792-6396F32E-3E9E-4500-9241-CA86CDE86B17Q30404192-B3E10465-CBA6-4088-BE77-67A0A5662E52Q30495922-2A57CFC8-A342-4A85-BBB8-6423CDD9C523Q33581459-C27294F3-AEBA-4707-A704-59D31C53FC5CQ33603369-4A0CD339-FDF2-4FE3-8731-085D4BE01252Q33685948-AB6574B8-922A-4635-A814-AD7BAA62F94FQ33730511-DD81CBCF-6DF0-412C-96AE-C825DD63D706Q33772878-CF141E11-A9BC-40E1-A60F-4B304F53F7ADQ33902894-54C6BFA2-7D2F-452E-A6AA-DC8270B2F31BQ34557349-44FD85B4-AB95-4F5C-AF24-527F2EE649BCQ34580927-8E077BFC-2706-4320-8B7F-EB415FCA6066Q34837085-4A513E08-EE7C-4AA2-8F19-6B02BF244216Q35043416-0A327B1D-2E47-4630-B12C-AB5FB9FAAF09Q35532241-26E668BC-3F7E-47AB-96E3-36720AA5448CQ35925909-37898E32-EB0A-498C-A05F-AA4FF94C621AQ35962745-57153AEF-2EFD-40CD-8899-78110FB60249Q36013553-4F23D256-458D-4158-B56F-BE299F11079BQ36112540-E8503794-D680-449B-9577-142B3A56BB64Q36796140-8B7E3F6F-9060-4B3C-9B92-06A4FFF188EAQ36800732-4C92C99C-8D7E-40D0-9E48-0B616E6400B7Q36846587-FAE6D486-AC4C-4455-87E8-61C86FDDEF0AQ36910693-46466407-B328-42AE-ADD6-06D9517E3272Q36929590-981C1DBC-CE04-4FD8-B271-51C8097CB8E5Q37039735-B4CA575A-4282-43E8-B934-B3F0182DF1DAQ37105136-E9D17B73-EF84-458A-9AD4-9A98A99469ADQ37210742-7E54B628-8BF5-4A87-836B-ED06E48D9ACDQ37223610-0E19D630-B4CC-4366-9A59-DFBB6759FD57Q37277966-0E0EC3F3-ED7F-45F6-9C7B-B3B5DC6A785BQ37282758-F364BA73-4CF4-4212-B8FE-ADB7C4BF74BBQ37320446-086BA4DF-4C95-4CB4-AA50-2077A8A0F75FQ37407901-195CCFA9-147F-4C78-A0C3-1A41D04B3E6FQ37495641-6552480E-E9AA-4212-BC56-7BF559362FD4Q37823358-BD3DAF02-2A03-4F26-B814-600C0B52AF0CQ37891173-96E4E9F0-2A9E-4E1B-A29B-70DD0FA93404
P2860
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@ast
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@en
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@nl
type
label
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@ast
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@en
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@nl
prefLabel
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@ast
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@en
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@nl
P1433
P1476
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
@en
P2093
P304
P356
10.2337/DIABETES.50.2007.S160
P407
P478
50 Suppl 1
P577
2001-02-01T00:00:00Z